These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32656646)

  • 1. Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.
    Wahlestedt C; Khorkova O
    Cell Mol Neurobiol; 2021 Jul; 41(5):849-853. PubMed ID: 32656646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
    Monine M; Norris D; Wang Y; Nestorov I
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct intraventricular delivery of drugs to the rodent central nervous system.
    DeVos SL; Miller TM
    J Vis Exp; 2013 May; (75):e50326. PubMed ID: 23712122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
    Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system.
    Sullivan JM; Mazur C; Wolf DA; Horky L; Currier N; Fitzsimmons B; Hesterman J; Pauplis R; Haller S; Powers B; Tayefeh L; DeBrosse-Serra B; Hoppin J; Kordasiewicz H; Swayze EE; Verma A
    J Transl Med; 2020 Aug; 18(1):309. PubMed ID: 32771027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System.
    Kennedy Z; Gilbert JW; Godinho BMDC
    Methods Mol Biol; 2022; 2434():345-353. PubMed ID: 35213030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal distribution and metabolism of 2'-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
    Butler M; Hayes CS; Chappell A; Murray SF; Yaksh TL; Hua XY
    Neuroscience; 2005; 131(3):705-15. PubMed ID: 15730875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections.
    Metz T; Kuijper EC; van Roon-Mom WMC
    Methods Mol Biol; 2022; 2434():333-341. PubMed ID: 35213029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.
    Zeniya S; Kuwahara H; Daizo K; Watari A; Kondoh M; Yoshida-Tanaka K; Kaburagi H; Asada K; Nagata T; Nagahama M; Yagi K; Yokota T
    J Control Release; 2018 Aug; 283():126-134. PubMed ID: 29753959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression along the cerebral-spinal axis after regional gene delivery.
    Meuli-Simmen C; Liu Y; Yeo TT; Liggitt D; Tu G; Yang T; Meuli M; Knauer S; Heath TD; Longo FM; Debs RJ
    Hum Gene Ther; 1999 Nov; 10(16):2689-700. PubMed ID: 10566897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.
    Lee CE; Kest B; Jenab S; Inturrisi CE
    Brain Res Mol Brain Res; 1997 Aug; 48(1):17-22. PubMed ID: 9379841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier.
    Barker SJ; Thayer MB; Kim C; Tatarakis D; Simon MJ; Dial R; Nilewski L; Wells RC; Zhou Y; Afetian M; Akkapeddi P; Chappell A; Chew KS; Chow J; Clemens A; Discenza CB; Dugas JC; Dwyer C; Earr T; Ha C; Ho YS; Huynh D; Lozano EI; Jayaraman S; Kwan W; Mahon C; Pizzo M; Robles-Colmenares Y; Roche E; Sanders L; Stergioulis A; Tong R; Tran H; Zuchero Y; Estrada AA; Gadkar K; Koth CMM; Sanchez PE; Thorne RG; Watts RJ; Sandmann T; Kane LA; Rigo F; Dennis MS; Lewcock JW; DeVos SL
    Sci Transl Med; 2024 Aug; 16(760):eadi2245. PubMed ID: 39141703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Save Your Maximum Tolerated Dose: How to Diagnose Procedure-Related Spinal Cord Lesions After Lumbar Intrathecal Bolus Administration of Oligonucleotides in Cynomolgus Monkeys.
    Korte S; Luft J; von Keutz A; Runge F; Mecklenburg L; Wozniak MM; Zander S; Ludwig FT; Pajaziti B; Romeike A; Korytko P
    Int J Toxicol; 2020; 39(6):510-517. PubMed ID: 32856507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of phosphorothioate oligodeoxynucleotide antisense transport across the blood-brain barrier.
    Banks WA
    Methods Mol Biol; 2011; 789():337-42. PubMed ID: 21922419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simple, rapid, and robust intrathecal catheterization method in the rat.
    Mazur C; Fitzsimmons B; Kamme F; Nichols B; Powers B; Wancewicz E
    J Neurosci Methods; 2017 Mar; 280():36-46. PubMed ID: 28163066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier.
    Min HS; Kim HJ; Naito M; Ogura S; Toh K; Hayashi K; Kim BS; Fukushima S; Anraku Y; Miyata K; Kataoka K
    Angew Chem Int Ed Engl; 2020 May; 59(21):8173-8180. PubMed ID: 31995252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
    Nagata T; Dwyer CA; Yoshida-Tanaka K; Ihara K; Ohyagi M; Kaburagi H; Miyata H; Ebihara S; Yoshioka K; Ishii T; Miyata K; Miyata K; Powers B; Igari T; Yamamoto S; Arimura N; Hirabayashi H; Uchihara T; Hara RI; Wada T; Bennett CF; Seth PP; Rigo F; Yokota T
    Nat Biotechnol; 2021 Dec; 39(12):1529-1536. PubMed ID: 34385691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of Radioactively Labeled Splice Modulating Antisense Oligonucleotides After Intracerebroventricular and Intrathecal Injection in Mice.
    Metz T; Welling MM; Suidgeest E; Nieuwenhuize E; de Vlaam T; Curtis D; Hailu TT; van der Weerd L; van Roon-Mom WMC
    Nucleic Acid Ther; 2024 Feb; 34(1):26-34. PubMed ID: 38386285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
    Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
    PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration.
    Jafar-Nejad P; Powers B; Soriano A; Zhao H; Norris DA; Matson J; DeBrosse-Serra B; Watson J; Narayanan P; Chun SJ; Mazur C; Kordasiewicz H; Swayze EE; Rigo F
    Nucleic Acids Res; 2021 Jan; 49(2):657-673. PubMed ID: 33367834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.